PL
PL · PL · PL-100496827
Celldemic
ATC J07BB02
Last synced from URPL (Poland) on
Identification
ManufacturerSeqirus Netherlands B.V.
CountryPL (PL)
ATC codeJ07BB02
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Zawiesina do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": null,
"packaging": "Rp ¦ EU/1/24/1806/001 ¦ 154301\n1 amp.-strzyk. 0,5 ml",
"substance": null,
"common_name": "Szczepionka przeciw grypie odzwierzęcej (H5N1) (antygen powierzchniowy), inaktywowana, z adiuwantem, przygotowana w hodowli komórek",
"pl_product_id": "100496827",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code J07BB02.
- BEAdjupanrixGlaxoSmithKline Biologicals
- FIAdjupanrixGlaxoSmithKline Biologicals SA
- PLAdjupanrixGlaxoSmithKline Biologicals S.A.
- ISAdjupanrixGlaxoSmithKline Biologicals S.A.*
- DKAdjupanrixGlaxoSmithKline Biologicals S.A.
- CZADJUPANRIXGlaxoSmithKline Biologicals S.A., Rixensart
- IEAdjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.
- NLAdjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieGlaxoSmithKline Biologicals S.A.
Access this data programmatically
Query Celldemic and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.